Myomo Inc. (NYSE American: MYO) announced that its MyoPro powered arm brace will be available through Ottobock Care clinics across the United States. The collaboration aims to provide access to the device for individuals with upper extremity impairment caused by stroke, brachial plexus injury, or other neurological conditions.

Ottobock Care operates over 50 patient care centers nationwide and specializes in prosthetic and orthotic solutions. The company will offer the MyoPro device to patients seeking to regain arm and hand function.

"The MyoPro fits well into our strategy to position our O&P clinics as leaders in providing enhanced neuro-robotic solutions to our patient population," said Kevin Heidenreich, Head of Patient Services at Ottobock Care. The company already provides lower limb mobility solutions including the C-Brace powered knee-ankle-foot-orthosis.

Myomo has trained Ottobock Care clinicians across multiple regions to support the implementation. "Since Medicare and a growing number of health insurance plans are covering the cost of a MyoPro on a case-by-case basis for their beneficiaries, we are able to meet this large unmet need of these patients," said Paul R. Gudonis, Myomo's Chairman and Chief Executive Officer.

The MyoPro device uses EMG sensors to detect muscle signals and restore function to weakened or paralyzed arms. Ottobock Care has fitted several patients with the device, according to the company's press release.

Myomo develops wearable medical robotics for patients with neurological disorders and upper-limb paralysis. The Burlington, Massachusetts-based company markets the MyoPro as a powered upper-limb orthosis for patients with conditions including stroke, brachial plexus injury, and traumatic brain or spinal cord injury.